Menu Search
Equities

Diaceutics PLC

7DC:DEU

Diaceutics PLC

Actions
  • Price (EUR)--
  • Today's Change--
  • Shares traded0.00
  • 1 Year change--
  • Beta--
Data delayed at least 15 minutes.
More ▼
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Financials data is unavailable for this security.

Inc stmt in GBPIncome statement in GBPView more

Year on year Diaceutics PLC's net income fell from a gain of 724.00k to a loss of 1.75m despite revenues that grew 21.51% from 19.50m to 23.70m. An increase in the selling, general and administrative costs as a percentage of sales from 83.47% to 96.14% was a component in the falling net income despite rising revenues.
Gross margin83.30%
Net profit margin-10.90%
Operating margin-17.00%
Return on assets-6.22%
Return on equity-7.13%
Return on investment-6.90%
More ▼

Cash flow in GBPView more

In 2023, cash reserves at Diaceutics PLC fell by 3.17m. However, the company earned 1.31m from its operations for a Cash Flow Margin of 5.53%. In addition the company used 4.21m on investing activities and also paid 239.00k in financing cash flows.
Cash flow per share0.027
Price/Cash flow per share49.64
Book value per share0.4573
Tangible book value per share0.2859
More ▼

Balance sheet in GBPView more

Diaceutics PLC has little financial risk as the capital structure does not rely on leverage.
Current ratio4.85
Quick ratio--
Total debt/total equity0.0293
Total debt/total capital0.0284
More ▼

Growth rates in GBP

SmartText is unavailable
EPS growth(5 years)--
EPS (TTM) vs
TTM 1 year ago		-5,086.15
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.